FATE THERAPEUTICS, INC. (FATE) Return on equity 2016–2025
FATE THERAPEUTICS, INC. (FATE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-65.8%FY2025 · since FY2016: -45.7% → -65.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -65.8% | -7.4 pp |
| FY2024 | -58.4% | -14.8 pp |
| FY2023 | -43.7% | +14.5 pp |
| FY2022 | -58.2% | -27.0 pp |
| FY2021 | -31.3% | +13.8 pp |
| FY2020 | -45.1% | -5.0 pp |
| FY2019 | -40.1% | +1.4 pp |
| FY2018 | -41.5% | +14.1 pp |
| FY2017 | -55.6% | -9.9 pp |
| FY2016 | -45.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice